您要查找的是不是:
- Cisapride was effective in the treatment of DGP patients. 西沙必利是治疗DGP的有效药物。
- Results:Different dose of SD and Cisapride could pro... 结果:3组中药及西沙必利均能促进胃肠运动。
- Methods: 845 patients were divided into 3 groups.Then treated them with ZLD, prepulsid and primperan. 方法:将845例功能性消化不良的患者分为3组,分别用术芍连防汤、普瑞博思、胃复安治疗。
- Objective To observe the effect of Cisapride on postoperative colonic peristalsis. 目的观察西沙比利对结肠术后肠运动功能的影响。
- Cisapride should be added as adjunct treatment in postoperative caner after colonectal surgery. 结论西沙比利可以促进结肠手术后肠蠕动的恢复,加快患者术后康复。
- Cisapride administration in DGP can improve gastric motility and decrease MTL concentration. 西沙比利在改善糖尿病患者MMC的同时 ,使MTL降低。
- Objective:To evaluate the therapeutic effect of cisapride on diabetic gastroparesis (DGP). 目的 :探讨全胃肠道促动力药物西沙必利对糖尿病性胃轻瘫 (DGP)的治疗作用。
- Cisapride, which can reduce total and segmental CTT, is an effective drug in chronic functional constipation. 西沙必利能显著缩短慢性功能性便秘患者的全结肠及各节段结肠转运时间,可常规用于慢性功能性便秘患者。
- Cisapride and mucosa protective agent should be added for patients with RE with acid and base reflux. 对有酸、碱反流的RE应加用西沙必利和粘膜保护剂。
- Conclusion:Cisapride and romitidine were more national, basic level-suiting treating drug for RE. 结论:西沙必利、雷尼替丁是较为理想的治疗轻、中度RE的药物。
- Results\ Prepulsid and Chaizhi Mixture could distinctly accelerate the evacuation and improve the propulsive function of mic... 结果普瑞博思和柴枳合剂可明显促进胃排空和小肠推进,阿托品和芍甘合剂则有明显抑制作用。
- The groups were dealt with high, medium and low dosages of Leweiyin, with Cisapride and with Xiangshaliujun Pill. 分别给予高中低剂量乐胃饮、西沙必利、香砂六君丸,放免法测定血清胃泌素和血浆胃动素。
- Treatment group(34 cases)was treated with Shenghong pill,and control group(36 cases)with Cisapride. 治疗组34例用胜红丸加减治疗,对照组36例用西沙必利治疗,其它治疗方法两组相同,疗程2周。
- Conclusion: Combination of omeptazole and cisapride is more effective on the treatment of esophagitis. 结论:洛赛克与西沙比利联合使用治疗反流性食管炎效果较好。
- As a new type of gastroenteric prokinetic drug, mosapride citrate tablet is more prospective than domperidone and cisapride to treat DGP. 枸橼酸莫沙必利片是一种比吗丁啉片、西沙必利片更有前途的治疗 DGP的新型促消化道动力药
- Three months later, group DM were divided into three groups: DGP(group D, 20), therapy of Cisapride(group X, 20) and Atropine test(group A, 20). 3个月后再将DM组分为DGP组(D组)、西沙必利治疗组(X组)和阿托品试验组(A组),每组各20只。
- Objective To study the relationship betw een functional dyspepsia ( F D) and gastric em ptying,and also the therapeutic effect of cisapride on F D. 目的探讨功能性消化不良与胃排空的关系及普瑞博思的治疗作用。
- Objective To investigate colonic transit time (CTT) in normal subjects and evaluate the effect of cisapride on CTT on chronic functional constipation. 目的了解国人结肠转运时间的正常值,并探讨西沙必利对慢性功能性便秘患者的结肠转运时间(CTT)的作用。
- Objective:To compare the efficiency and economic cost of mosapride,cisapride,clebopride and domperidone in the treatment of functional dyspepsia. 目的:比较莫沙必利、西沙必利、氯波必利及多潘立酮治疗功能性消化不良的疗效与药物经济学成本。
- Methods: 80 patients are devided into 2 groups randomly,A team uses Cisapride, B team uses Cisapride and Prozac.The treatment continue 4 weeks. 方法80例病人随机分成两组,A组用西沙必利治疗,B组用西沙必利加百优解,治疗4周后观察疗效。